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112a Sunday, March 1, 2009Apoptotic cell death is involved in normal and pathologic cardiac function. Ap-
optosis is pivotal in normal developmental cardiogenesis and yet unregulated
cardiomyocyte loss via apoptosis contributes to cardiac degeneration in heart
failure. There is emerging evidence that distinct populations of cardiomyocytes
may exhibit differential susceptibility to apoptosis. We showed that alternative
splicing of the cardiac ryanodine receptor (RyR2) modulated the susceptibility
of cardiomyocytes toCa2þ-linked apoptosis (George et al., (2007)). Specifically,
a 24bp splice variant (encoding VTGSQRSK inserted distal to residue 3715 in
human RyR2) suppressed homeostatic and agonist-evoked Ca2þ fluxes in cardi-
omyocytes. We proposed that alternative splicing of RyR2 may represent
a mechanism for ‘tuning’ pro- and anti-apoptotic Ca2þ fluxes. Our data supports
the concept that the 24bp splice insertion stabilises RyR2-mediated Ca2þ re-
lease, andwe tested this hypothesis using single channel and cellular approaches.
In single channel experiments using CHAPS-solubilised, sucrose gradient-en-
riched preparations incorporated into PE bilayers, we investigated the effects
of synthetic peptides containing VTGSQRSK on the Ca2þ sensitivity of re-
combinant human RyR2 channels devoid of alternatively spliced insertions
(RyR2/). In a complementary approach we used confocal imaging to deter-
mine the effects of these peptides on Ca2þ handling in living cardiomyocytes.
Peptideswere injected into the nucleus and cytoplasmof synchronously-coupled
HL-1 cells (that exclusively express RyR2/) and cellular Ca2þ fluxeswere an-
alysed using the multi-parametric Synchronicity-Amplitude-Length and Vari-
ability of Oscillation (SALVO) program that describes the ‘contractile’ and
‘non-contractile’ aspects of cellular Ca2þ handling. In both approaches, peptides
encoding a splice insertion that did not protect cells from Ca2þ-linked apoptosis
(FAIDSLCGFG), or scrambled sequenceswere used as controls. Our data shows
the utility of these complementary approaches in determining the mechanistic
basis of altered cellular Ca2þ handlingmediated by alternative splicing of RyR2.
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Inactivation of Kþ channels occurs by the interaction of the pore with NH2-ter-
minal sequences. Synthetic peptides corresponding to these sequences were ap-
plied to the purified mouse cardiac ryanodine receptor type 2 (RyR2) and single
channel activity was recorded in planar lipid bilayers. The wild type (WT)
Shaker B NH2-peptide MAAVAGLYGLGEDRQHRKKQ induced a block of
the open RyR2 channel in a concentration and voltage-dependent manner,
but also when the channel displayed a ryanodine-modified state [Mead et al.,
J. Membrane Biol., 1998]. In the latter condition, in a 200 mM KCl buffer
when the holding potential was at þ50 mV, the open probability decreased
by a factor of 2 (p¼0.001, n¼10 channels for control and n¼5 for WT peptide)
mainly due to a 4-fold reduction (p<0.01, n¼10 channels for control and n¼5
for WT peptide) of the mean open time in the presence of 20 mMWT peptide. It
is noteworthy that the peptide at 20 mM had no effect in a 600 mM KCl buffer,
suggesting the importance of charged residues in the blocking effect on RyR2.
Furthermore we designed a mutant peptide where the amino acid Alanine in po-
sitions 3 and 5 was replaced by Glutamine residues, giving a less hydrophobic
feature to the peptide. The mutant peptide at 20 mM in a 200 mM KCl buffer
was less effective than the WT peptide, while showing a different mechanism
of action. These findings are consistent with the idea that RyR2 contains well
organised charged and hydrophobic residues in its conduction pathway and that
they may play a general role in the ion translocation mechanisms of the sarco-
plasmic reticulum Ca2þ release channel.
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Imperatoxin A (IpTxa) is a 33 amino acid peptide toxin from the African scor-
pion Pandinus imperator. Its definitive structural and functional characteristics
designate it as a member of the calcin family, a unique group of peptide toxins,
which to date includes Hemicalcin (HCa), Hadrucalcin (HdCa), IpTxa, Maur-
ocalcin (MCa), and Opicalcins 1 & 2 (Opi 1 & 2). Calcins are unified by 1)
a compact, globular structure containing an inhibitor cystine knot, 2) positive
net charge, 3) the ability to activate ryanodine receptors (RyR) with high affin-
ity and selectivity, and 4) presumed or confirmed cell-penetrating capabilities.
Previous studies have demonstrated the ability of MCa to carry a fluorescentcargo to the interior of intact cells, and we have used a similar method to con-
firm that IpTxa is also a cell-penetrator. In addition, we have demonstrated
IpTxa’s ability to transiently enhance calcium release from the sarcoplasmic re-
ticulum (SR) of intact cells. In the current study, we used confocal microscopy
to explore the effects of IpTxa on saponin-permeabilized cells. Perfusion of
10nM IpTxa on cells resulted in a dramatic reduction of sparks to as low as
1% of control within two minutes. This effect was even more pronounced
and rapid in the presence of 50nM toxin, with complete ablation of sparks in
less than 1 minute. At the same time, mean fluorescence is often increased in
our scans relative to control, although rapid application of caffeine reveals
that SR calcium content is retained. Our results suggest that IpTxa depletes cal-
cium from the SR, a hypothesis that would explain not only the ablation of
sparks, but also the transient nature of enhanced calcium release in intact cells
observed upon perfusion with IpTxa.
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This study investigates the novel block from the cytosolic face of mRyR2 by
three hERG blocking agents. For this purpose, astemizole (A), terfenadine (T)
and chloroquine (C) were investigated based on their different affinities of
hERG block (IC50 ¼ 0.9 nM, 56–204 nM and 2500 nM) and differences in
their proposed mechanisms of action at the cytosolic face of ion channels.
As well as exhibiting high affinity block of hERG, these blockers exhibit
half maximal block of multiple ion channel types at concentrations exceeding
1  106 M. Whilst mRyR2 lacks the key residues (Y652 and F656) involved
in high affinity block of hERG it does possess a wide pore containing a high
density of hydrophobic residues. Therefore the potential exists for mRyR2,
like hERG, to be blocked by a diverse range of compounds with high affinity.
The aim of this study is to examine the properties/mechanisms of mRyR2
block to identify areas within mRyR2 that may be involved in drug binding.
Similar to their action in non-hERG ion channels, these compounds block
mRyR2 within the micromolar range (IC50; (A) - 16.12 5 2.12 mM; (T) -
30.04 5 4.81 mM and (C) - 17.73 5 5.14 mM; n ¼ 5) at þ 50 mV. Whilst
all blockers reduce the single channel current amplitude to ~ 95 % of control
levels, astemizole and terfenadine induce additional blocking states, whilst
also allowing channel closure during periods of block. Chloroquine exhibits
briefer blocking events, indicating a faster off rate and no additional reduced
conductance states observed. This work was funded by the British Heart
Foundation.
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Consumption of green tea has been found to closely correlate with a lower risk
of heart disease and reduced cardiovascular mortality. Extracted from green
leaves, a group of catechin polyphenols appears to be responsible for these ben-
eficial cardiovascular effects. Studies have shown that epigallocatechin-3-gal-
late (EGCG), one of the most abundant and potent catechins, can modulate
myocardial contractility through some unknown mechanisms. Recent evidence
suggests a role for Naþ/Hþ and Naþ/Ca2þ exchangers in the ionotropic effects
of EGCG in rat heart. Here we report that cardiac Ca2þ release channel - RyR2
serves as a possible molecular target of EGCG that may be responsible for am-
plified Ca2þ transients, enhanced ventricular contractility and increased cell
shortening in cardiac myocytes. In single isolated mouse ventricular myocytes
EGCG (5mM) increased peak systolic Ca2þ transient amplitude, increased de-
cay of the Ca2þ transient, increased fractional shortening and increased con-
traction and relaxation velocities. To assess the direct interaction of EGCG
with RyR2, both purified and membrane-bound RyR2 single channels were re-
constituted in planar lipid bilayers. In the presence of 0.5mM EGCG, the open
probability (Po) increased from Po¼0.012 in the control state to Po¼0.387. Us-
ing [3H]ryanodine as a probe to assess channel conformational states, our data
further indicate that (1) EGCG dose-dependently enhanced junctional SRmem-
brane-bound RyR2 channel activity and (2) EGCG increased Ca2þ-induced
Ca2þ activation of RyR2 (EC50 ¼ 7.0 and 1.7 mM for control and EGCG,
respectively). In summary, our data are consistent with previous reports for
positive inotropic and lusitropic effects by EGCG on heart cells. In addition,
our data clearly supports a role of EGCG in modulating cardiac E-C coupling
through interacting with RyR2 channel complex. Supported by K01 AR51519
to GR and P01 AR52354.
